Home / Conditions / Non-small Cell Lung Cancer

Non-small Cell Lung Cancer: when insurers say no, reviewers often say yes

In 44 published external-review decisions involving non-small cell lung cancer, independent physician reviewers overturned the insurer’s denial 68.2% of the time.

Published decisions
44
2001–2026
Overturned
68.2%
30 denials reversed
How to use this in your appeal

These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for non-small cell lung cancer was denied, the published record says the denial is worth fighting.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for non-small cell lung cancer? 68.2% won.

Explain my denial — free